Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lifecore Biomedical Inc 3515 LYMAN BOULEVARD CHASKA MN 55318 USA

www.lifecore.com Employees: 406 P: 952-368-4300

Sector:

Medical

Description:

Lifecore Biomedical Inc. is a fully integrated contract development and manufacturing organization which offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. Lifecore Biomedical Inc., formerly known as Landec Corporation, is based in CHASKA, Minn.

Key Statistics

Overview:

Market Capitalization, $K 245,028
Enterprise Value, $K 435,618
Shares Outstanding, K 37,466
Float, K 25,484
% Float 68.02%
Short Interest, K 2,731
Short Float 7.29%
Days to Cover 33.93
Short Volume Ratio 0.49
% of Insider Shareholders 31.98%
% of Institutional Shareholders 83.36%

Financials:

Annual Sales, $ 128,870 K
Annual Net Income, $ -38,720 K
Last Quarter Sales, $ 31,110 K
Last Quarter Net Income, $ -9,990 K
EBIT, $ -21,130 K
EBITDA, $ -13,100 K

Growth:

1-Year Return -32.61%
3-Year Return 291.62%
5-Year Return -42.68%
5-Year Revenue Growth -78.17%
5-Year Earnings Growth -296.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 11/06/25
Next Earnings Date 03/16/26 [BMO]
Earnings Per Share ttm -0.83
EPS Growth vs. Prev Qtr -190.00%
EPS Growth vs. Prev Year 45.28%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

LFCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,211.09%
Return-on-Assets % -10.61%
Profit Margin % -30.05%
Debt/Equity 4.36
Price/Sales 1.77
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.98
Interest Coverage -0.77
60-Month Beta 0.62
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar